EMMA · Emmaus Life Sciences, Inc.
$0.03
+0.01 (+22.99%)
At close · Aug 21
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because the Company's existing cash balance and anticipated cash flows cannot satisfy its current debt and ongoing obligations, combined with the uncommitted nature of the Company's financing plans, there is substantial doubt about the Company’s ability to continue as a going concern for 12 months from the date that these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$2.25M
Shares
70.19M
Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.
Holders: 1
Total Value: $55,322
Total Shares: 57,034
Holder Concentration
Across 1 13F filersTop Holder
100.0%
of institutional value
Top 5
100.0%
of institutional value
Top 10
100.0%
of institutional value
HHI
10,000
Highly concentrated
| Holder | Value (USD) | % of 13F | Shares | Type | Filed | Open |
|---|---|---|---|---|---|---|
| Small Diametric Capital, LP | $55,322 | 100.00% | 57,034 | Shares | 2020-11-13 |